News & Updates

Show Multimedia Only

Novel pill keeps hopes up in infertile women ≤40 years undergoing IVF/ICSI

25 Jul 2024 by

In the phase II OXOART2 trial presented at ESHRE 2024, the first-in-class, non-hormonal, oral agent OXO-001 increases implantation and pregnancy rates in infertile women ≤40 years undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).

Novel pill keeps hopes up in infertile women ≤40 years undergoing IVF/ICSI

25 Jul 2024

Response-adapted ultralow-dose RT may improve indolent orbital B-cell lymphoma outcomes

25 Jul 2024

Response-adapted radiation therapy (RT) shows promise in the treatment of indolent orbital B-cell lymphoma, conferring high local control rates while reducing radiation exposure, according to the results of a phase II nonrandomized controlled trial.

Response-adapted ultralow-dose RT may improve indolent orbital B-cell lymphoma outcomes

25 Jul 2024

Investigational IL-13 inhibitor shows therapeutic potential in atopic dermatitis

24 Jul 2024

The IL-13 inhibitor cendakimab appears to be beneficial in the treatment of atopic dermatitis (AD), with the results of a phase II study showing that a dosing schedule of 720 mg once weekly helps reduce the severity of the said condition.

Investigational IL-13 inhibitor shows therapeutic potential in atopic dermatitis

24 Jul 2024

Meta-analysis strengthens case for argatroban use in patients with END after stroke

24 Jul 2024 by

Argatroban appears to reduce neurological deficits in acute ischaemic stroke (AIS) patients with early neurological deterioration (END) who are undergoing thrombolytic therapy, without increasing the risk of symptomatic intracranial haemorrhage, according to the results of a meta-analysis.

Meta-analysis strengthens case for argatroban use in patients with END after stroke

24 Jul 2024

Endometrial cancer in women under 40 years of age

24 Jul 2024 by

Endometrial cancer affects the lining of the uterus (ie, the endometrium). In Singapore, endometrial cancer is the most common gynaecological cancer, with an increasing incidence over the past few decades, corresponding to global trends associated with factors such as changing lifestyles, obesity, and hormonal influences.

Endometrial cancer in women under 40 years of age

24 Jul 2024

ADAPTABLE: No sex-based difference seen in aspirin effectiveness for secondary ASCVD prevention

23 Jul 2024 by

Sex does not appear to influence the effectiveness of aspirin at either high or low doses for the secondary prevention of atherosclerotic cardiovascular disease (ASCVD), according to the secondary analysis of the ADAPTABLE* trial.

ADAPTABLE: No sex-based difference seen in aspirin effectiveness for secondary ASCVD prevention

23 Jul 2024

Is it safe to use conditionally ordered LMWH in cancer patients with VTE?

23 Jul 2024 by

Conditional orders of low molecular weight heparin (LMWH) based on platelet values appears safe and effective in the treatment of venous thromboembolism (VTE) in patients with malignant haematology (MH) experiencing thrombocytopenia, a study has shown. In addition, worsening or new VTE has not been reported among study participants.

Is it safe to use conditionally ordered LMWH in cancer patients with VTE?

23 Jul 2024

Nipocalimab + SoC improves MG-ADL scores in adults with myasthenia gravis

23 Jul 2024 by

Adding nipocalimab to standard-of-care (SoC) treatment significantly improves Myasthenia Gravis-Activities of Daily Living (MG-ADL) scores in patients with generalized MG (gMG), according to the pivotal phase III Vivacity-MG3 study presented at EAN 2024.

Nipocalimab + SoC improves MG-ADL scores in adults with myasthenia gravis

23 Jul 2024

Bimekizumab may protect against uveitis in axial spondyloarthritis

22 Jul 2024

In the treatment of patients with axial spondyloarthritis (axSpA), the dual IL-17A/F inhibitor bimekizumab appears to lower the risk of uveitis, according to a study.

Bimekizumab may protect against uveitis in axial spondyloarthritis

22 Jul 2024

Antibiotic overtreatment prevalent in children with PPE/PE

22 Jul 2024 by

Children with parapneumonic effusion (PPE) or pleural empyema (PE) are often overly treated with antibiotics, particularly the frequent use of antibiotic combination therapy, reports a Germany study.

Antibiotic overtreatment prevalent in children with PPE/PE

22 Jul 2024

News & Updates

Filter by Specialty:

Specialty:

Novel pill keeps hopes up in infertile women ≤40 years undergoing IVF/ICSI

Novel pill keeps hopes up in infertile women ≤40 years undergoing IVF/ICSI

Response-adapted ultralow-dose RT may improve indolent orbital B-cell lymphoma outcomes

Response-adapted ultralow-dose RT may improve indolent orbital B-cell lymphoma outcomes

Investigational IL-13 inhibitor shows therapeutic potential in atopic dermatitis

Investigational IL-13 inhibitor shows therapeutic potential in atopic dermatitis

Meta-analysis strengthens case for argatroban use in patients with END after stroke

Meta-analysis strengthens case for argatroban use in patients with END after stroke

Endometrial cancer in women under 40 years of age

Endometrial cancer in women under 40 years of age

ADAPTABLE: No sex-based difference seen in aspirin effectiveness for secondary ASCVD prevention

ADAPTABLE: No sex-based difference seen in aspirin effectiveness for secondary ASCVD prevention

Is it safe to use conditionally ordered LMWH in cancer patients with VTE?

Is it safe to use conditionally ordered LMWH in cancer patients with VTE?

Nipocalimab + SoC improves MG-ADL scores in adults with myasthenia gravis

Nipocalimab + SoC improves MG-ADL scores in adults with myasthenia gravis

Bimekizumab may protect against uveitis in axial spondyloarthritis

Bimekizumab may protect against uveitis in axial spondyloarthritis

Antibiotic overtreatment prevalent in children with PPE/PE

Antibiotic overtreatment prevalent in children with PPE/PE